Urdu Translation And Cross-Cultural Validation of the Foot And Ankle Disability Index

August 11, 2023 updated by: Waseem Javaid, Sehat Medical Complex

Urdu Translation And Cross-Cultural Validation of the Foot And Ankle Disability Index for the Patients With Chronic Ankle Instability

The goal of this Cross-cultural validation study is to Urdu translate and cross-cultural validation of Foot and Ankle Disability Index for the Patients with Chronic Ankle Instability. The main question it aims to answer was:

• To Translate Foot and Ankle Disability Index in Urdu and to find out the Validity and Reliability for Patients with Chronic Ankle Instability.

Data collection procedure would be, FADI Urdu version was introduced and the patients were asked to fill FADI Urdu version. The questionnaire was filled again by the same participants after one week to assess the test retest reliability. Questionnaire was conducted to have the best result. After the ethical approval, participants who meet the inclusion criteria and who were free from exclusion criteria were explained about the objectives of this study. Only those who gave consent were included in the study.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The foot and ankle are common sources of pain and disability, with approximately 2 million people in the United States per year affected by foot pain. As many as 25% of sports injuries have been attributed to the foot or ankle, with ankle sprains accounting for up to 45% of all injuries in some sports. The Foot and Ankle Disability Index (FADI) were designed to assess functional limitations related to foot and ankle conditions. Therefore, it is used to assess the patients with chronic ankle instability. The FADI was originally developed in English. It has been translated and validated in Italian languages and showed excellent reliability and responsiveness. To cross culturally validate the FADI in Urdu, the FADI will be translated in Urdu to assess the chronic ankle instability patients to check the instability. Convenience sampling technique will be used in this study. A study will be conducted at Pakistan Sports Board Lahore including 10 athletes for 1st stage and 50 Athelets in 2nd stage. The aim of this study was to translate FADI in Urdu and to find out the validity and reliability of Urdu version of FADI in patients with chronic ankle instability. Reliability and validity of FADI in Urdu version was evaluated by calculating Cronbach's alpha, intra-class correlation co-efficient and Pearson/ spearman rank correlation co-efficient. SPSS 25 was used for data analysis.

Study Type

Observational

Enrollment (Actual)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Punjab
      • Lahore, Punjab, Pakistan, 54000
        • Pakistan sports Board Lahore

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Athletes at Pakistan Sports Board with Chronic Ankle Instability.

Description

Inclusion Criteria:

  • A history of ankle sprain with pain and/or limping for more than 1 day,
  • Chronic weakness, pain, or instability that they attributed to the initial injury
  • Giving way in the last 6 months.
  • Able to read Urdu Language

Exclusion Criteria:

  • Bilateral ankle instability
  • History of ankle fracture
  • Ankle injury within 3 months of participation
  • History of anterior cruciate ligament injury
  • History of balance disorder
  • Current participation in supervised physical rehabilitation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Urdu version of Foot and Ankle Disability Index
Time Frame: at Day 7
The Foot and Ankle Disability Index is a 34-item questionnaire divided into two subscales: the Foot and Ankle Disability Index and the Foot and Ankle Disability Index Sport. The FADI has 26 items, and the FADI Sport has 8. The FADI contains 4 pain related items and 22 activity related items. The FADI Sport contains 8 activity related items. It assesses more difficult tasks that are essential to sport. The FADI Sport is unique in that it is a population-specific subscale designed for athletes. It is designed to address this need by detecting deficits in higher functioning subjects.
at Day 7
Foot and ankle ability measure (FAAM)
Time Frame: at Day 7
The Foot and Ankle Ability Measure (FAAM) is a self-report outcome instrument developed to assess physical function for individuals with foot and ankle related impairments. It is a 29-item questionnaire divided into two subscales: the Foot and Ankle Ability Measure, 21-item Activities of Daily Living Subscale and the Foot and Ankle Ability Measure, 8-item Sports Subscale. Each item is scored on a 5-point Likert scale (4 to 0) from 'no difficulty at all' to 'unable to do'. Item score totals, which range from 0 to 84 for the ADL subscale and 0 to 32 for the Sports subscale, were transformed to percentage scores. Higher scores represent higher levels of function for each subscale, with 100% representing no dysfunction.
at Day 7

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Saira Akbar Bodla, MS-SPT, Riphah International University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 28, 2023

Primary Completion (Actual)

June 30, 2023

Study Completion (Actual)

July 25, 2023

Study Registration Dates

First Submitted

January 27, 2023

First Submitted That Met QC Criteria

February 7, 2023

First Posted (Actual)

February 17, 2023

Study Record Updates

Last Update Posted (Actual)

August 15, 2023

Last Update Submitted That Met QC Criteria

August 11, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • sairaakbar0444

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ankle Disorders Injuries

Clinical Trials on Validation study

Subscribe